This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ohr Pharmaceuticals, Inc. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Innovations of Kyle Armbruster in Squalamine Research
Introduction
Kyle Armbruster is an accomplished inventor based in Plymouth Meeting, Pennsylvania. He holds a patent that focuses on the development of polymorphic and amorphous salt forms of squalamine dilactate. This invention has significant implications for therapeutic applications, particularly in the field of medicine.
Latest Patents
Armbruster's patent, titled "Polymorphic and amorphous salt forms of squalamine dilactate," relates to the synthesis of select squalamine salts. The patent outlines methods for their synthesis, therapeutic uses, and advantages concerning manufacturing, product stability, and toxicity. Specifically, it addresses various forms of the dilactate salt of squalamine and their utility in inhibiting neovascularization and endothelial cell proliferation.
Career Highlights
Throughout his career, Armbruster has worked with notable companies such as Ohr Pharmaceuticals, Inc. and Enterin, Inc. His contributions to these organizations have been instrumental in advancing research and development in the pharmaceutical sector.
Collaborations
Armbruster has collaborated with professionals like Eric Chellquist and Mary Doubleday, who have contributed to his work in various capacities. Their teamwork has fostered innovation and progress in the projects they have undertaken together.
Conclusion
Kyle Armbruster's work in the field of squalamine research exemplifies the impact of innovative thinking in medicine. His patent and collaborations highlight the importance of teamwork and dedication in advancing therapeutic solutions.